Merit Financial Group LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Merit Financial Group LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,811 shares of the medical equipment provider's stock after acquiring an additional 1,147 shares during the period. Merit Financial Group LLC's holdings in Intuitive Surgical were worth $3,869,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $6,509,000. U.S. Capital Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 19.6% in the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 2,265 shares of the medical equipment provider's stock valued at $1,182,000 after purchasing an additional 371 shares in the last quarter. Alliance Wealth Advisors LLC UT bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $278,000. Finally, Mather Group LLC. raised its stake in Intuitive Surgical by 10.1% during the fourth quarter. Mather Group LLC. now owns 2,195 shares of the medical equipment provider's stock worth $1,146,000 after acquiring an additional 202 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $0.98 during mid-day trading on Friday, hitting $557.08. The company's stock had a trading volume of 1,103,774 shares, compared to its average volume of 1,642,177. The company has a market cap of $199.67 billion, a PE ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. The company's fifty day simple moving average is $520.78 and its 200-day simple moving average is $539.13. Intuitive Surgical, Inc. has a 52 week low of $405.08 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the company posted $1.50 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 25,443 shares of company stock worth $12,692,195 in the last quarter. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ISRG. Citigroup restated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday. Evercore ISI lowered their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Piper Sandler cut their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.